Legal & General Group PLC Ngm Biopharmaceuticals Inc Transaction History

Legal & General Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.05 - $3.37 $26,126 - $83,852	-24,882 Reduced 89.15%	3,029 $3,000
Q2 2023 Aug 14, 2023	BUY	$2.44 - $4.53 $37,841 - $70,255	15,509 Added 125.05%	27,911 $72,000
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $2,961 - $4,298	796 Added 6.86%	12,402 $50,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $11,834 - $16,609	940 Added 8.81%	11,606 $151,000
Q2 2022 Aug 22, 2022	BUY	$10.58 - $17.5 $1,565 - $2,590	148 Added 1.41%	10,666 $137,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $122,169 - $158,789	6,063 Added 136.09%	10,518 $221,000
Q2 2021 Aug 12, 2021	BUY	$15.06 - $30.03 $25,797 - $51,441	1,713 Added 62.47%	4,455 $87,000
Q1 2021 May 17, 2021	SELL	$24.99 - $31.93 $2,698 - $3,448	-108 Reduced 3.79%	2,742 $80,000
Q3 2020 Nov 13, 2020	SELL	$15.59 - $19.97 $14,716 - $18,851	-944 Reduced 24.88%	2,850 $45,000
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $538 - $1,056	45 Added 1.2%	3,794 $75,000
Q1 2020 May 14, 2020	SELL	$10.0 - $19.51 $12,570 - $24,524	-1,257 Reduced 25.11%	3,749 $49,000
Q4 2019 Feb 13, 2020	BUY	$9.97 - $20.28 $39,939 - $81,241	4,006 Added 400.6%	5,006 $92,000
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $12,560 - $16,600	1,000 New	1,000 $15,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.